Preliminary studies suggest conolidine may well inhibit distinct ion channels, lowering neuronal excitability and limiting discomfort indicators. This system is especially suitable in neuropathic soreness, where abnormal signaling leads to persistent pain. Moreover, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to